Saturday, October 3, 2026

USD/EUR Went Down By Over 2% In The Last 21 Sessions

ViaNews Editorial Team

August 22, 2024

USD/EUR Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.75% for the last 21 sessions. At 21:10 EST on Wednesday, 21 August, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 0.112% up from its 52-week low and 6.28% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a negative 0.13%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.43% (last week), 0.29% (last month), and 0.26% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy price forecast: hovers around 145.20 post-fed minutes release. According to FXStreet on Wednesday, 21 August, "If USD/JPY drops below 145.00, the August 6 daily low of 143.61 will be exposed. ", "The USD/JPY trims some of its earlier gains after July's Federal Reserve's meeting minutes hinted the US central bank could ease policy as soon as September. "
  • Usd/jpy edges lower near 146.00 on the weaker US dollar, hawkish boj. According to FXStreet on Tuesday, 20 August, "The USD/JPY pair trades in negative territory for the third consecutive day near 146.05 during the Asian trading hours on Tuesday. "
  • According to FXStreet on Tuesday, 20 August, "This resulted in a sharp unwind of yen carry trades, bringing USD/JPY down to as low as 142.", "Japan had intervened to support the JPY in April-May as well as July this year, and risks of intervention are heightened if USD/JPY is to trade above 150 again."
  • According to FXStreet on Tuesday, 20 August, "The BoJ then surprised everyone by raising interest rates, while the Fed announced on the same day that it would cut rates in September, before a weak US jobs report two days later sent USD/JPY even lower.", "We therefore expect the JPY to weaken again and USD/JPY to strengthen over the course of next year."
  • Usd/jpy: clashing uncertainties – rabobank. According to FXStreet on Wednesday, 21 August, "That has not been the case in USD/JPY this summer, Rabobank's Senior FX Strategist Jane Foley notes.", "Most activity in the last couple of weeks has been within the 145 to 147 area and there is a solid chance that this will continue to broadly hold USD/JPY in the near-term. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com